These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 9022487)

  • 1. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis.
    Ziakas PD; Pavlou M; Voulgarelis M
    Obstet Gynecol; 2010 Jun; 115(6):1256-1262. PubMed ID: 20502298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.
    Farquharson RG; Quenby S; Greaves M
    Obstet Gynecol; 2002 Sep; 100(3):408-13. PubMed ID: 12220757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
    Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
    Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.
    Empson M; Lassere M; Craig J; Scott J
    Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002859. PubMed ID: 15846641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
    de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study.
    Naru T; Khan RS; Ali R
    East Mediterr Health J; 2010 Mar; 16(3):308-12. PubMed ID: 20795446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies.
    Goel N; Tuli A; Choudhry R
    Med Sci Monit; 2006 Mar; 12(3):CR132-6. PubMed ID: 16501426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
    Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
    Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
    Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
    Kutteh WH
    Am J Obstet Gynecol; 1996 May; 174(5):1584-9. PubMed ID: 9065133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome.
    Venkat-Raman N; Backos M; Teoh TG; Lo WT; Regan L
    Obstet Gynecol; 2001 Aug; 98(2):235-42. PubMed ID: 11506839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome.
    Diejomaoh MF; Al-Azemi MM; Bandar A; Egbase PE; Jirous J; Al-Othman S; Bukhadour N; Al-Sweih N
    Arch Gynecol Obstet; 2002 Apr; 266(2):61-6. PubMed ID: 12049296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.